Libo Liu

Libo Liu

Auto-generated profile, based on publicly available information

Libo Liu

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2014 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
ZLZhen Li
Zhen Li
XLXiao-Bai Liu
Xiao-Bai Liu
YLYun-Hui Liu
Yun-Hui Liu
YXYi-Xue Xue
Yi-Xue Xue
PWPing Wang
Ping Wang
LLLi-Bo Liu
Li-Bo Liu

1 April 2015
Verified
Journal Article
Closed access
LGLina Gao
Lina Gao
SYShuang Yang
Shuang Yang
JLJunting Liu
Junting Liu
LLLibo Liu
Libo Liu
To investigate the protective effects of 5-hydroxy-1-methylhyantoin (HM ) on paraquat (PQ)-induced nephrotoxicity in rat and its possible mechanism. Twenty-four male Sprague-Dawley (SD) rats were randomly divided into four groups: namely control, PQ, vitamin C and HMH groups, with 6 rats in each group. The rats in control group were given an injection of 2 mg/kg of normal saline intraperitoneally. The rats in PQ group were given an injection of 50 mg/kg of PQ intraperitoneally. The rats in vitamin C and HMH groups were given 1 mmol/kg of vitamin C or HMH through gastric tube right after PQ injection. The hydroxyl free radical scavenging ability of HMH and vitamin C was determined by Fenton method. Blood sample was collected after 24 hours of PQ treatment, then the animals were sacrificed and renal tissues were harvested. Blood urea nitrogen (BUN), serum creatinine (SCr), protein content of renal cortex, blood malondialdehyde (MDA), reduced glutathione (GSH) and superoxide dismutase (SOD) activity were determined. Both vitamin C and HMH showed a very good ability to scavenge hydroxyl radicals, and the 50% inhibiting concentration (IC₅₀) was both 4.02 mg/mL. Compared with control group, serum BUN, SCr and MDA in renal tissue were significantly increased in PQ group, and the protein, GSH contents and SOD activity were significantly decreased [BUN (mmol/L): 40.80 ± 2.49 vs. 13.67 ± 1.58, SCr (μmol/L): 163.46 ± 8.67 vs. 51.80 ± 4.37, MDA (nmol/g): 7.51 ± 0.23 vs. 4.52 ± 0.33, protein (μmol/L): 0.94 ± 0.14 vs. 1.35 ± 0.10, GSH (mg/g): 1.08 ± 0.48 vs. 3.30 ± 0.44, SOD (kU/L): 70.74 ± 6.42 vs. 112.89 ± 8.72, all P < 0.01 ]. Compared with PQ group, serum BUN and SCr and MDA in kidney tissue in vitamin C and HMH groups were significantly decreased, and GSH content and SOD activity in kidney tissue were significantly elevated [BUN mmol/L): 22.64 ± 2.36, 18.71 ± 5.23 vs. 40.80 ± 2.49, SCr (μmol/L): 97.28 ± 4.81, 89.20 ± 6.72 vs. 163.46 ± 8.67, MDA (nmol/g): 4.67 ± 0.31, 4.21 ± 0.42 vs. 7.51 ± 0.23, GSH (mg/g): 1.78 ± 0.10, 1.86 ± 0.39 vs. 1.08 ± 0.48, SOD (kU/L): 98.69 ± 5.43, 103.76 ± 4.45 vs. 70.74 ± 6.42, all P < 0.01]. Compared with vitamin C group, HMH could significantly reduce SCr contents P < 0.05). There were no differences in reduction PQ-induced BUN, MDA content, and effect on GSH content and SOD activity between vitamin C group and HMH group (all P > 0.05). HMH can protect the kidney against PQ-induced nephrotoxicity, and the mechanism of which maybe attributed to its anti-oxidation property and ability to scavenge hydroxyl radical.

1 June 2025 in Cardiovascular Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
JTJinfan Tian
Jinfan Tian
LLLibo Liu
Libo Liu
XYXueyao Yang
Xueyao Yang
WXWenxiao Xia
Wenxiao Xia
HZHuijuan Zuo
Huijuan Zuo
XSXiantao Song
Xiantao Song
Background: The impact of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) on myocardial function remains controversial. This study aims to evaluate changes in myocardial function following CTO-PCI using cardiac magnetic resonance (CMR) imaging and to identify the patient subgroups that derive the greatest benefit from CTO artery recanalization. Methods: We retrospectively screened 652 patients diagnosed with single-vessel CTO through coronary angiography at Beijing Anzhen Hospital between December 2014 and July 2023. Among these, 303 patients underwent baseline CMR imaging, and 115 completed follow-up imaging. A total of 108 patients met the inclusion criteria, with 71 receiving PCI and 37 undergoing optimal medical therapy (OMT). Myocardial viability and cardiac function indices, including left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and late gadolinium enhancement (LGE) were assessed using CMR. In the subgroup analysis, patients were categorized by LVEF based on clinical consensus (normal: ≥50%; decreased: <50%). Paired t-tests or non-parametric tests were used to compare pre- and post-treatment cardiac function, and Cox regression analysis was performed to identify factors influencing myocardial functional recovery. Results: There were no significant differences between the PCI and OMT groups in baseline characteristics, including age (56.96±10.69 vs. 54.16±11.32 years, P=0.21) and gender distribution [57 (80.3%) vs. 33 (89.2%), P=0.24]. No differences were observed between the PCI and OMT groups in LVEF (61.00%±9.40% vs. 59.68%±9.33%, P=0.50), LVEDV (126.53±31.41 vs. 125.93±29.26 mL, P=0.93), or LVESV [47.09 (35.22, 61.11) vs. 51.41 (36.73, 62.07) mL, P=0.68] at a median follow-up time of 12 months. Additionally, no changes in LVEF, LVEDV, or LVESV were found following PCI (P>0.05). However, in patients with baseline LVEF <50% and segmental LGE ≤50%, LVEF improved post-PCI [46.93% (40.14%, 47.49%) vs. 61.13% (47.48%, 64.54%), P=0.01]. In patients with baseline LVEF 50%, LVEF was not significantly affected by PCI [43.22% (40.23%, 45.54%) vs. 46.03% (40.75%, 59.06%), P=0.11]. Patients with LVEF ≥50% showed no myocardial function improvements post-PCI, regardless of segmental LGE percentages (P>0.05). Conclusions: Baseline LVEF and myocardial viability assessed via quantitative CMR imaging before CTO-PCI may help select patients who will benefit from the procedure. Although overall LVEF did not improve following CTO-PCI, patients with baseline LVEF <50% and segmental LGE ≤50% benefited more, suggesting the procedure can enhance myocardial function recovery in certain patient groups and confirming the safety and efficacy of CTO-PCI.